查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1776809

醫療食品市場：全球產業分析、市場規模、佔有率、成長、趨勢與未來預測（2025-2032）

Medical Foods Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 195 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球醫療食品市場的全面分析報告。本報告對重要市場動態進行了全面評估，包括市場促進因素、趨勢、機會和挑戰，並對市場結構提供了深入的見解。報告提供了獨家資料和統計資料，概述了全球醫療食品市場的預測成長軌跡（2025-2032年）。

關鍵見解

  • 醫療食品市場規模（2025年）：255億美元
  • 市場規模預測（以金額為準，2032年）：395億美元
  • 全球市場成長率（2025-2032年年複合成長率）：6.5%

醫療食品市場-分析範圍

醫療食品是專門為治療疾病或病症而配製的膳食管理食品，這些疾病或病症具有獨特的營養需求，無法透過常規飲食來滿足。這些產品在醫生監督下食用，常用於治療阿茲海默症、慢性腎臟病、代謝紊亂和胃腸道疾病等疾病。醫療食品市場服務於醫院、診所、長期照護機構和家庭護理機構，提供各種形式的產品，例如粉劑、液體和膠囊。市場成長的驅動力包括慢性病盛行率的上升、人們對疾病特異性營養的認知的不斷提高，以及需要有針對性飲食干預的全球人口老化。

市場成長動力：

全球醫療食品市場受多種關鍵因素驅動，其中包括日益加重的慢性病和文明病負擔，這些疾病需要個人化營養療法。阿茲海默症和帕金森氏症等神經系統疾病、糖尿病以及胃腸道疾病的盛行率不斷上升，也推動了醫療食品需求的成長。此外，預防性醫療保健的轉變，加上營養科學的進步和針對特異性疾病配方的開發，也支撐了市場的成長。將醫療食品視為獨立類別的法律規範也為產品開發和商業化提供了一個穩定的環境。

市場限制：

儘管前景光明，醫療食品市場仍面臨著許多挑戰，例如嚴格的監管要求、高昂的產品開發成本以及有限的償付框架。臨床檢驗和科學有效性證明的需求增加了產品上市所需的時間和成本。此外，患者和醫療保健提供者對醫療食品的角色和益處缺乏認知，阻礙了市場滲透，尤其是在新興市場。全球監管分類和標籤要求的差異也阻礙了製造商的國際擴張。

市場機會：

醫療食品市場蘊藏著顯著的成長機會，這得益於研發投入的不斷增加、營養基因組學的進步以及個性化營養需求的不斷成長。電商平台和遠端醫療服務的擴展將提升醫療食品的可近性，尤其對於居家管理慢性病的患者而言。此外，對腸道健康、微生物組調節和免疫支持的日益關注將為醫療食品的應用開闢新的途徑。製藥、生物技術和營養相關企業之間的策略合作將進一步促進產品創新和市場擴張。彌補臨床教育方面的差距並簡化監管途徑對於充分發揮市場的潛力非常重要。

本報告回答的關鍵問題

  • 推動全球醫療食品市場成長的主要因素有哪些？
  • 哪些疾病領域和配方影響醫療食品的開發和採用？
  • 監管政策如何影響各地區的醫療食品商業化？
  • 醫療食品市場的主要企業有哪些？他們採取什麼策略來擴大其市場影響力？
  • 全球醫療食品市場有哪些新趨勢和未來前景？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子：相關性和影響力

第3章 加值分析

  • 表單採用分析
  • 監管狀況
  • 疾病流行病學
  • 償付方案
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第4章 全球醫療食品市場展望：

  • 主要亮點
    • 市場規模及年成長率（以金額為準）
    • 絕對的商機
  • 市場規模分析與預測（以金額為準）
    • 歷史市場規模分析（以金額為準，2019-2024）
    • 市場規模分析與預測（以金額為準，2025-2032）
  • 全球醫療食品市場展望：依形態
    • 引言/主要發現
    • 歷史市場規模分析：依形態（以金額為準，2019-2024）
    • 市場規模分析與預測：依形態（以金額為準，2025-2032）
      • 錠劑
      • 粉末
      • 液體
      • 其他
    • 市場吸引力分析：依形態
  • 全球醫療食品市場前景：依應用
    • 引言/主要發現
    • 歷史市場規模分析：依應用（以金額為準，2019-2024）
    • 市場規模分析和預測：依應用（以金額為準，2025-2032）
      • 慢性腎臟病（CKD）
      • 阿茲海默症
      • 糖尿病神經病變
      • 注意力不足過動症（ADHD）
      • 憂鬱症
      • 罕見疾病
      • 癌症
      • 其他
    • 市場吸引力分析：依應用
  • 全球醫療食品市場展望：依銷售管道
    • 引言/主要發現
    • 歷史市場規模分析：依銷售管道（以金額為準，2019-2024年）
    • 市場規模分析和預測：依銷售管道（以金額為準，2025-2032年）
      • 超級市場和大賣場
      • 線上管道
      • 藥局和藥房
      • 醫院
      • 其他
    • 市場吸引力分析：依銷售管道

第5章 全球醫療食品市場展望：依地區

  • 主要亮點
  • 歷史市場規模分析：依地區（以金額為準，2019-2024年）
  • 市場規模分析及預測：依地區（以金額為準，2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：區域

第6章 北美醫療食品市場展望

第7章 歐洲醫療食品市場展望

第8章 東亞醫療食品市場展望

第9章 南亞和大洋洲醫療食品市場展望

第10章 拉丁美洲醫療食品市場展望

第11章 中東與非洲醫療食品市場展望

第12章 競爭格局

  • 市場佔有率分析（2024年）
  • 市場結構
    • 競爭強度圖：依市場
    • 競爭儀錶板
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Nestle Health Science
    • Abbott Laboratories
    • Danone SA（Nutricia Advanced Medical Nutrition）
    • Fresenius Kabi AG
    • Mead Johnson Nutrition（part of Reckitt Benckiser）
    • Primus Pharmaceuticals, Inc.
    • Targeted Medical Pharma, Inc.
    • Medtrition, Inc.
    • Metagenics, Inc.
    • Alfasigma SpA
    • Ajinomoto Cambrooke, Inc.
    • BioMedical Nutrition, Inc.
    • Meiji Holdings Co., Ltd.
    • B. Braun Melsungen AG
    • Entia Biosciences Inc.
    • Others

第13章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP26854

Persistence Market Research has recently released a comprehensive report on the worldwide market for medical foods. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global medical foods market from 2025 to 2032.

Key Insights:

  • Medical Foods Market Size (2025E): USD 25.5 Billion
  • Projected Market Value (2032F): USD 39.5 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.5%

Medical Foods Market - Report Scope:

Medical foods are specially formulated and intended for the dietary management of diseases or conditions that have distinctive nutritional needs not met by normal diets. These products are consumed under medical supervision and are typically used for conditions such as Alzheimer's disease, chronic kidney disease, metabolic disorders, and gastrointestinal diseases. The medical foods market serves hospitals, clinics, long-term care facilities, and homecare settings, offering products in various forms such as powders, liquids, and capsules. Market growth is driven by the rising prevalence of chronic diseases, increased awareness of disease-specific nutrition, and an aging global population requiring targeted dietary interventions.

Market Growth Drivers:

The global medical foods market is propelled by several key factors, including the growing burden of chronic and lifestyle-related diseases, which demand personalized nutritional therapies. Rising incidences of neurological disorders such as Alzheimer's and Parkinson's disease, along with diabetes and gastrointestinal conditions, contribute to the increased demand for medical foods. Additionally, the shift toward preventative healthcare, coupled with advances in nutritional science and the development of disease-specific formulations, supports market growth. Regulatory frameworks recognizing medical foods as a distinct category also provide a stable environment for product development and commercialization.

Market Restraints:

Despite a promising outlook, the medical foods market faces challenges such as stringent regulatory requirements, high product development costs, and limited reimbursement frameworks. The need for clinical validation and scientific substantiation for efficacy adds to the time and expense required to bring products to market. Furthermore, lack of awareness among patients and healthcare providers regarding the role and benefits of medical foods can hinder market penetration, especially in developing regions. Variability in global regulatory classifications and labeling requirements also poses barriers to international expansion for manufacturers.

Market Opportunities:

The medical foods market presents notable growth opportunities driven by increasing R&D investment, advances in nutrigenomics, and growing demand for personalized nutrition. The expansion of e-commerce platforms and telehealth services enhances access to medical foods, particularly for patients managing chronic conditions at home. Additionally, the rising focus on gut health, microbiome modulation, and immune support opens new avenues for medical food applications. Strategic collaborations between pharmaceutical, biotech, and nutrition companies further contribute to product innovation and market expansion. Addressing gaps in clinical education and streamlining regulatory pathways are critical to unlocking the full potential of this market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the medical foods market globally?
  • Which disease areas and formulations are influencing medical food development and adoption?
  • How are regulatory policies shaping the commercialization of medical foods across different regions?
  • Who are the key players in the medical foods market, and what strategies are they employing to enhance their market presence?
  • What are the emerging trends and future outlook for the global medical foods market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in developing disease-specific formulations, enhancing palatability, and improving nutritional delivery. Collaborations with academic institutions, healthcare professionals, and patient advocacy groups support market education and clinical integration. Mergers, acquisitions, and strategic partnerships enable portfolio diversification and geographic expansion, while digital health tools are increasingly leveraged to support patient compliance and remote monitoring.

Key Companies Profiled:

  • Nestle Health Science
  • Abbott Laboratories
  • Danone S.A. (Nutricia Advanced Medical Nutrition)
  • Fresenius Kabi AG
  • Mead Johnson Nutrition (part of Reckitt Benckiser)
  • Primus Pharmaceuticals, Inc.
  • Targeted Medical Pharma, Inc.
  • Medtrition, Inc.
  • Metagenics, Inc.
  • Alfasigma S.p.A.
  • Ajinomoto Cambrooke, Inc.
  • BioMedical Nutrition, Inc.
  • Meiji Holdings Co., Ltd.
  • B. Braun Melsungen AG
  • Entia Biosciences Inc.
  • Others

Medical Foods Market Research Segmentation:

The medical foods market encompasses a diverse range of product types, disease targets, routes of administration, and end-user segments, addressing various patient populations.

By Form

  • Pills
  • Powders
  • Liquids
  • Others

By Application

  • Chronic Kidney Disease (CKD)
  • Alzheimer's Disease
  • Diabetic Neuropathy
  • ADHD (Attention Deficit Hyperactivity Disorder)
  • Depression
  • Orphan Diseases
  • Cancer
  • Others

By Sales Channels

  • Supermarkets & Hypermarkets
  • Online Channels
  • Drug Stores & Pharmacies
  • Hospitals
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Foods Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Form Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Disease Epidemiology
  • 3.4. Reimbursement Scenario
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Medical Foods Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Medical Foods Market Outlook: Form
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Form, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
      • 4.3.3.1. Pills
      • 4.3.3.2. Powders
      • 4.3.3.3. Liquids
      • 4.3.3.4. Others
    • 4.3.4. Market Attractiveness Analysis: Form
  • 4.4. Global Medical Foods Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Chronic Kidney Disease (CKD)
      • 4.4.3.2. Alzheimer's Disease
      • 4.4.3.3. Diabetic Neuropathy
      • 4.4.3.4. ADHD (attention deficit hyperactivity disorder)
      • 4.4.3.5. Depression
      • 4.4.3.6. Orphan Diseases
      • 4.4.3.7. Cancer
      • 4.4.3.8. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Medical Foods Market Outlook: Sales Channel
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Sales Channel, 2019-2024
    • 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
      • 4.5.3.1. Supermarkets & Hypermarkets
      • 4.5.3.2. Online Channels
      • 4.5.3.3. Drug Stores & Pharmacies
      • 4.5.3.4. Hospitals
      • 4.5.3.5. Others
    • 4.5.4. Market Attractiveness Analysis: Sales Channel

5. Global Medical Foods Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Medical Foods Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Form
    • 6.2.3. By Application
    • 6.2.4. By Sales Channel
  • 6.3. Market Size (US$ Bn) Analysis and Forecast By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 6.4.1. Pills
    • 6.4.2. Powders
    • 6.4.3. Liquids
    • 6.4.4. Others
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Chronic Kidney Disease (CKD)
    • 6.5.2. Alzheimer's Disease
    • 6.5.3. Diabetic Neuropathy
    • 6.5.4. ADHD (attention deficit hyperactivity disorder)
    • 6.5.5. Depression
    • 6.5.6. Orphan Diseases
    • 6.5.7. Cancer
    • 6.5.8. Others
  • 6.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 6.6.1. Supermarkets & Hypermarkets
    • 6.6.2. Online Channels
    • 6.6.3. Drug Stores & Pharmacies
    • 6.6.4. Hospitals
    • 6.6.5. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Medical Foods Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Form
    • 7.2.3. By Application
    • 7.2.4. By Sales Channel
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 7.4.1. Pills
    • 7.4.2. Powders
    • 7.4.3. Liquids
    • 7.4.4. Others
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Chronic Kidney Disease (CKD)
    • 7.5.2. Alzheimer's Disease
    • 7.5.3. Diabetic Neuropathy
    • 7.5.4. ADHD (attention deficit hyperactivity disorder)
    • 7.5.5. Depression
    • 7.5.6. Orphan Diseases
    • 7.5.7. Cancer
    • 7.5.8. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 7.6.1. Supermarkets & Hypermarkets
    • 7.6.2. Online Channels
    • 7.6.3. Drug Stores & Pharmacies
    • 7.6.4. Hospitals
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Medical Foods Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Form
    • 8.2.3. By Application
    • 8.2.4. By Sales Channel
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 8.4.1. Pills
    • 8.4.2. Powders
    • 8.4.3. Liquids
    • 8.4.4. Others
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Chronic Kidney Disease (CKD)
    • 8.5.2. Alzheimer's Disease
    • 8.5.3. Diabetic Neuropathy
    • 8.5.4. ADHD (attention deficit hyperactivity disorder)
    • 8.5.5. Depression
    • 8.5.6. Orphan Diseases
    • 8.5.7. Cancer
    • 8.5.8. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 8.6.1. Supermarkets & Hypermarkets
    • 8.6.2. Online Channels
    • 8.6.3. Drug Stores & Pharmacies
    • 8.6.4. Hospitals
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Medical Foods Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Form
    • 9.2.3. By Application
    • 9.2.4. By Sales Channel
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 9.4.1. Pills
    • 9.4.2. Powders
    • 9.4.3. Liquids
    • 9.4.4. Others
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Chronic Kidney Disease (CKD)
    • 9.5.2. Alzheimer's Disease
    • 9.5.3. Diabetic Neuropathy
    • 9.5.4. ADHD (attention deficit hyperactivity disorder)
    • 9.5.5. Depression
    • 9.5.6. Orphan Diseases
    • 9.5.7. Cancer
    • 9.5.8. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 9.6.1. Supermarkets & Hypermarkets
    • 9.6.2. Online Channels
    • 9.6.3. Drug Stores & Pharmacies
    • 9.6.4. Hospitals
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Medical Foods Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Form
    • 10.2.3. By Application
    • 10.2.4. By Sales Channel
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 10.4.1. Pills
    • 10.4.2. Powders
    • 10.4.3. Liquids
    • 10.4.4. Others
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Chronic Kidney Disease (CKD)
    • 10.5.2. Alzheimer's Disease
    • 10.5.3. Diabetic Neuropathy
    • 10.5.4. ADHD (attention deficit hyperactivity disorder)
    • 10.5.5. Depression
    • 10.5.6. Orphan Diseases
    • 10.5.7. Cancer
    • 10.5.8. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 10.6.1. Supermarkets & Hypermarkets
    • 10.6.2. Online Channels
    • 10.6.3. Drug Stores & Pharmacies
    • 10.6.4. Hospitals
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Medical Foods Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Form
    • 11.2.3. By Application
    • 11.2.4. By Sales Channel
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 11.4.1. Pills
    • 11.4.2. Powders
    • 11.4.3. Liquids
    • 11.4.4. Others
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Chronic Kidney Disease (CKD)
    • 11.5.2. Alzheimer's Disease
    • 11.5.3. Diabetic Neuropathy
    • 11.5.4. ADHD (attention deficit hyperactivity disorder)
    • 11.5.5. Depression
    • 11.5.6. Orphan Diseases
    • 11.5.7. Cancer
    • 11.5.8. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Sales Channel, 2025-2032
    • 11.6.1. Supermarkets & Hypermarkets
    • 11.6.2. Online Channels
    • 11.6.3. Drug Stores & Pharmacies
    • 11.6.4. Hospitals
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Nestle Health Science
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Form
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abbott Laboratories
    • 12.3.3. Danone S.A. (Nutricia Advanced Medical Nutrition)
    • 12.3.4. Fresenius Kabi AG
    • 12.3.5. Mead Johnson Nutrition (part of Reckitt Benckiser)
    • 12.3.6. Primus Pharmaceuticals, Inc.
    • 12.3.7. Targeted Medical Pharma, Inc.
    • 12.3.8. Medtrition, Inc.
    • 12.3.9. Metagenics, Inc.
    • 12.3.10. Alfasigma S.p.A.
    • 12.3.11. Ajinomoto Cambrooke, Inc.
    • 12.3.12. BioMedical Nutrition, Inc.
    • 12.3.13. Meiji Holdings Co., Ltd.
    • 12.3.14. B. Braun Melsungen AG
    • 12.3.15. Entia Biosciences Inc.
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations